Related Articles
Survivin, Ki‑67 and tumor grade as predictors of response to docetaxel‑based neoadjuvant chemotherapy in locally advanced breast cancer
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Utility of initial MRI for predicting extent of residual disease after neoadjuvant chemotherapy: Analysis of 70 breast cancer patients
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer
Diffusion-weighted magnetic resonance imaging for assessment after neoadjuvant chemotherapy in breast cancer, based on morphological concepts